KLK3 and prostate carcinoma: For example, serum-derived exosomal PSA levels distinguish prostate cancer patients with remarkable accuracy [205], while ML models analyzing exosomal profiles in colorectal cancer outperform traditional biomarkers like CEA and CA19-9 [206].